USA - NASDAQ:STRM - US86323X2053 - Common Stock
The current stock price of STRM is 5.3332 USD. In the past month the price increased by 0.63%. In the past year, price decreased by -24.67%.
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| VEEV | VEEVA SYSTEMS INC-CLASS A | 39.39 | 48.11B | ||
| DOCS | DOXIMITY INC-CLASS A | 44.17 | 12.33B | ||
| WAY | WAYSTAR HOLDING CORP | 27.98 | 7.16B | ||
| HTFL | HEARTFLOW INC | N/A | 2.83B | ||
| CERT | CERTARA INC | 23.57 | 1.86B | ||
| SDGR | SCHRODINGER INC | N/A | 1.47B | ||
| TDOC | TELADOC HEALTH INC | N/A | 1.41B | ||
| PHR | PHREESIA INC | N/A | 1.35B | ||
| GDRX | GOODRX HOLDINGS INC-CLASS A | 9.31 | 1.13B | ||
| LFMDP | LIFEMD INC - LFMD 8 7/8 PERP | N/A | 1.07B | ||
| CTEV | CLARITEV CORP | N/A | 1.04B | ||
| CCLDO | CARECLOUD INC - CCLD 8 3/4 PERP | N/A | 878.14M |
Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organizations. The company is headquartered in Alpharetta, Georgia and currently employs 77 full-time employees. The firm delivers integrated solutions, technology-enabled services and analytics. The company operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The firm sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. The company offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. The company offers an array of professional services, including system implementation.
STREAMLINE HEALTH SOLUTIONS
2400 Old Milton Parkway, Box 1353
Alpharetta GEORGIA 30009 US
CEO: Wyche T. Tee Green
Employees: 77
Phone: 18889978732
Streamline Health Solutions, Inc. engages in the provision of transformational data-driven solutions for healthcare organizations. The company is headquartered in Alpharetta, Georgia and currently employs 77 full-time employees. The firm delivers integrated solutions, technology-enabled services and analytics. The company operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The firm sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. The company offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. The company offers an array of professional services, including system implementation.
The current stock price of STRM is 5.3332 USD. The price decreased by -0.13% in the last trading session.
STRM does not pay a dividend.
STRM has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
STREAMLINE HEALTH SOLUTIONS (STRM) currently has 77 employees.
STREAMLINE HEALTH SOLUTIONS (STRM) will report earnings on 2025-09-09.
ChartMill assigns a technical rating of 9 / 10 to STRM. When comparing the yearly performance of all stocks, STRM is one of the better performing stocks in the market, outperforming 93.38% of all stocks.
ChartMill assigns a fundamental rating of 1 / 10 to STRM. Both the profitability and financial health of STRM have multiple concerns.
Over the last trailing twelve months STRM reported a non-GAAP Earnings per Share(EPS) of -2.23. The EPS decreased by -127.84% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -25.3% | ||
| ROE | -82% | ||
| Debt/Equity | 0.18 |
For the next year, analysts expect an EPS growth of 15.38% and a revenue growth 4.04% for STRM